3rd Quarter - Report

THE JACKSON LABORATORY for THE JACKSON LABORATORY

Firm
Client
Income
—
Expenses
$30,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Transportation TRA

Issues related to the shipment of animals for use in biomedical research. Issues pertaining to taxable transportation benefits for employees of 501(c)3 nonprofit institutions. Rural transportation needs.

LobbyistCovered position, as disclosed
JILL HOMER STEWART —

Contacted: Transportation, Dept of (DOT); SENATE; HOUSE OF REPRESENTATIVES

Immigration IMM

Issues pertaining to recruiting researchers and obtaining visas for foreign citizen employees of nonprofit research institutions.

LobbyistCovered position, as disclosed
JILL HOMER STEWART —

Contacted: Transportation, Dept of (DOT); SENATE; HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

Issues pertaining to basic science research and biomedical research. The background and use of animal models in biomedical research. National Institutes of Health and the Federal Bureau of Investigation scrutinizing researchers with global research collaborations. Issues pertaining to COVID-19 diagnosis and animal model discovery.

LobbyistCovered position, as disclosed
JILL HOMER STEWART New Legislative Director - Representative Peter J. Viclosky Staff Assistant -Representative Robert A. Weygand Staff Assistant - Senator Dianne Feinstein

Contacted: Transportation, Dept of (DOT); SENATE; HOUSE OF REPRESENTATIVES

Agriculture AGR

Issues pertaining to animal rights activism and the Animal Welfare Act.

LobbyistCovered position, as disclosed
JILL HOMER STEWART —

Contacted: Transportation, Dept of (DOT); HOUSE OF REPRESENTATIVES; SENATE

Animals ANI

Issues pertaining to animal rights activism, biomedical research, animals used in biomedical research. Issues pertaining to the transportation and shipment of laboratory animals.

LobbyistCovered position, as disclosed
JILL HOMER STEWART —

Contacted: HOUSE OF REPRESENTATIVES; Transportation, Dept of (DOT); SENATE

Health Issues HCR

Issues pertaining to authorization and funding for disease research. S.850 and HR 1873, the HOPE for Alzheimer's Disease Act. S 901 and HR 1903, the Younger Onset Alzheimer's Disease Act. Implementation of Public Law No: 115-406, the BOLD Infrastructure for Alzheimer's Act. Issues pertaining to COVID-19, including testing and animal model development.

LobbyistCovered position, as disclosed
JILL HOMER STEWART New —

Contacted: Transportation, Dept of (DOT); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1873 (116th), H.R. 1903 (116th), S. 850 (116th)

Budget/Appropriations BUD

Issues pertaining to funding for biomedical research, including annual appropriations for the National Institutes of Health and the National Science Foundation. COVID related relief packages. including: - HR 748, Coronavirus Aid, Relief, and Economic Security Act or the CARES Act. - HR 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act Funding issues pertaining to commuter transportation.

LobbyistCovered position, as disclosed
JILL HOMER STEWART —

Contacted: Transportation, Dept of (DOT); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 748 (116th), H.R. 6074 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.